nmpЖурнал им. Н.В. Склифосовского «Неотложная медицинская помощь»Russian Sklifosovsky Journal "Emergency Medical Care"2223-90222541-8017“N.V. Sklifosovsky Research Institute for Emergency Medicine”nmp-71Research ArticleВ ПОМОЩЬ ПРАКТИКУЮЩЕМУ ВРАЧУFOR PRACTICING PHYSICIANSТАКТИКА ВЕДЕНИЯ БОЛЬНОГО С КАРДИОГЕННЫМ ШОКОМ, ОБУСЛОВЛЕННЫМ ОСТРЫМ ИНФАРКТОМ МИОКАРДА: ДОКАЗАТЕЛЬНЫЕ ОСНОВЫ И РЕАЛЬНАЯ ПРАКТИКАMANAGEMENT TACTICS FOR PATIENTS WITH CARDIOGENIC SHOCk DUE TO ACUTE MYOCARDIAL INFARCTION: EVIDENCE BASE, AND ACTUAL PRACTICEГиляревскийС. Р.GiliarevskyS. R.

д.м.н., профессор старший научный сотрудник отделения неотложной кардиологии для больных инфарктом миокарда

sgilarevsky@rambler.ruРезванВ. В.RezvanV. V.КузьминаИ. М.KuzminaI. M.ЛопотовскийП. Ю.LopotovskyP. Yu.НИИ скорой помощи им. Н.В. Склифосовского ДЗ г. Москвы, МоскваРоссияSklifosovsky Research Institute for Emergency Medicine of Health department of Moscow, MoscowRussian Federation201421022016013844Copyright © Гиляревский С.Р., Резван В.В., Кузьмина И.М., Лопотовский П.Ю., 20162016Гиляревский С.Р., Резван В.В., Кузьмина И.М., Лопотовский П.Ю.Giliarevsky S.R., Rezvan V.V., Kuzmina I.M., Lopotovsky P.Y.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jnmp.ru/jour/article/view/71

РЕЗЮМЕ. Материал посвящен современным подходам к лечению больных, находящихся в состоянии кардиогенного шока, развившегося в результате острого инфаркта миокарда. Представлены данные о патогенезе, клинических проявлениях такого осложнения, а также подробно рассматриваются современные подходы к лечению подобных больных. Обсуждается проблема неудовлетворительных результатов лечения больных острым инфарктом миокарда, находящихся в состоянии кардиогенного шока, и возможные подходы к их улучшению. 

ABSTRACT. The article addresses current approaches to the management of cardiogenic shock developed in patients with acute myocardial infarction. The authors present the data on the pathogenesis, clinical manifestations of this complication, and also a detailed review of current approaches to the treatment of patients with cardiogenic shock. The authors discuss causes of poor outcomes in cardiogenic shock and possible ways of the improvement. 

кардиогенный шокострый инфаркт миокардаcardiogenic shockacute myocardial infarctionReferencesReynolds H.R., Hochman J.S. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008; 117: 686–697.Reynolds H.R., Hochman J.S. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008; 117: 686–697.Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294: 448–454.Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294: 448–454.Goldberg R.J., Samad N.A., Yarzebski J., et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999; 340: 1162–1168.Goldberg R.J., Samad N.A., Yarzebski J., et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999; 340: 1162–1168.Holmes D.R. Jr, Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995; 26: 668–674.Holmes D.R. Jr, Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995; 26: 668–674.Holmes D.R. Jr, Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999; 100: 2067–2073.Holmes D.R. Jr, Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999; 100: 2067–2073.Jeger R.V., Radovanovic D., Hunziker P.R., et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008; 149: 618–626.Jeger R.V., Radovanovic D., Hunziker P.R., et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008; 149: 618–626.Awad H.H., Anderson F.A. Jr, Gore J.M., et al. Cardiogenic shock compli￾cating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2012; 163: 963–971.Awad H.H., Anderson F.A. Jr, Gore J.M., et al. Cardiogenic shock compli￾cating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2012; 163: 963–971.Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999; 341: 625–634.Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999; 341: 625–634.Webb J.G., Sleeper L.A., Buller C.E., et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1084–1090.Webb J.G., Sleeper L.A., Buller C.E., et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1084–1090.Goldberg R.J., Spencer F.A., Gore J.M., et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119: 1211–1219.Goldberg R.J., Spencer F.A., Gore J.M., et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119: 1211–1219.Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001; 285: 190–192.Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001; 285: 190–192.Thiele H., Zeymer U., Neumann F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367: 1287–1296.Thiele H., Zeymer U., Neumann F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367: 1287–1296.Kohsaka S., Menon V., Lowe A.M., et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005; 165: 1643–1650.Kohsaka S., Menon V., Lowe A.M., et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005; 165: 1643–1650.Cooper H.A., Panza J.A. Cardiogenic Shock. Cardiol Clin 2013; 31: 567–580.Cooper H.A., Panza J.A. Cardiogenic Shock. Cardiol Clin 2013; 31: 567–580.Marik P.E., Baram M. Noninvasive hemodynamic monitoring in the intensive care unit. Crit Care Clin. 2007; 23: 383–400.Marik P.E., Baram M. Noninvasive hemodynamic monitoring in the intensive care unit. Crit Care Clin. 2007; 23: 383–400.O’Gara P.T., Kushner F.G., Ascheim D.D., et al. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61: e78–140.O’Gara P.T., Kushner F.G., Ascheim D.D., et al. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61: e78–140.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Lancet. 1986; 1: 397–402.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Lancet. 1986; 1: 397–402.In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group. Lancet 1990; 336: 71–75.In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group. Lancet 1990; 336: 71–75.Dunkman W.B., Leinbach R.C., Buckley M.J., et al. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation. 1972; 46: 465–477.Dunkman W.B., Leinbach R.C., Buckley M.J., et al. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation. 1972; 46: 465–477.Bates ER. Cardiogenic shock. In: Jeremias A, Brown D, editors. Cardiac intensive care. Philadelphia: Saunders; 2010. P. 212–224.Bates ER. Cardiogenic shock. In: Jeremias A, Brown D, editors. Cardiac intensive care. Philadelphia: Saunders; 2010. P. 212–224.Valente S., Lazzeri C., Vecchio S., et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007; 114: 176–182.Valente S., Lazzeri C., Vecchio S., et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007; 114: 176–182.De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362: 779–789.De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362: 779–789.O’Connor C.M., Rogers J.G. Evidence for overturning the guidelines in cardiogenic shock. N Engl J Med. 2012; 367: 1349–1350.O’Connor C.M., Rogers J.G. Evidence for overturning the guidelines in cardiogenic shock. N Engl J Med. 2012; 367: 1349–1350.Taylor J. 2012 ESC guidelines on acute myocardial infarction (STEMI). Eur Heart J. 2012; 33: 2501–2502.Taylor J. 2012 ESC guidelines on acute myocardial infarction (STEMI). Eur Heart J. 2012; 33: 2501–2502.Kar B., Basra S.S., Shah N.R., et al. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012; 125: 1809–1817.Kar B., Basra S.S., Shah N.R., et al. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012; 125: 1809–1817.Meyns B., Dens J., Sergeant P., et al. Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardio￾genic shock. Thorac Cardiovasc Surg. 2003; 51: 312–317.Meyns B., Dens J., Sergeant P., et al. Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardio￾genic shock. Thorac Cardiovasc Surg. 2003; 51: 312–317.Lauten A., Engstrom A.E., Jung C., et al. Percutaneous left-ventricular support with the Impella-2.5 – assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013; 6: 23–30.Lauten A., Engstrom A.E., Jung C., et al. Percutaneous left-ventricular support with the Impella-2.5 – assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013; 6: 23–30.Thiele H., Sick P., Boudriot E., et al. Randomized comparison of intra￾aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26: 1276–1283.Thiele H., Sick P., Boudriot E., et al. Randomized comparison of intra￾aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26: 1276–1283.Burkhoff D., Cohen H., Brunckhorst C., et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152: 469. e1–8.Burkhoff D., Cohen H., Brunckhorst C., et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152: 469. e1–8.Seyfarth M., Sibbing D., Bauer I., et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52: 1584–1588.Seyfarth M., Sibbing D., Bauer I., et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52: 1584–1588.Cheng J.M., den Uil C.A., Hoeks S.E., et al. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30: 2102–2108.Cheng J.M., den Uil C.A., Hoeks S.E., et al. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30: 2102–2108.Tang G.H., Malekan R., Kai M., et al. Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. J Thorac Cardiovasc Surg. 2013; 145: e32–33.Tang G.H., Malekan R., Kai M., et al. Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. J Thorac Cardiovasc Surg. 2013; 145: e32–33.Hochman J.S., Buller C.E., Sleeper L.A., et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1063–1070.Hochman J.S., Buller C.E., Sleeper L.A., et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1063–1070.Slater J., Brown R.J., Antonelli T.A., et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000; 36: 1117–1122.Slater J., Brown R.J., Antonelli T.A., et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000; 36: 1117–1122.Mittle S., Makaryus A.N., Mangion J. Role of contrast echocardiography in the assessment of myocardial rupture. Echocardiography. 2003; 20: 77–81.Mittle S., Makaryus A.N., Mangion J. Role of contrast echocardiography in the assessment of myocardial rupture. Echocardiography. 2003; 20: 77–81.Abedi-Valugerdi G., Gabrielsen A., Fux T., et al. Management of left ventricular rupture after myocardial infarction solely with ECMO. Circ Heart Fail. 2012; 5: e65–67.Abedi-Valugerdi G., Gabrielsen A., Fux T., et al. Management of left ventricular rupture after myocardial infarction solely with ECMO. Circ Heart Fail. 2012; 5: e65–67.Zoffoli G., Battaglia F., Venturini A., et al. A novel approach to ventricular rupture: clinical needs and surgical technique. Ann Thorac Surg. 2012; 93: 1002–1003.Zoffoli G., Battaglia F., Venturini A., et al. A novel approach to ventricular rupture: clinical needs and surgical technique. Ann Thorac Surg. 2012; 93: 1002–1003.Gueret P., Khalife K., Jobic Y., et al. Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry. Arch Cardiovasc Dis. 2008; 101: 41–47.Gueret P., Khalife K., Jobic Y., et al. Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry. Arch Cardiovasc Dis. 2008; 101: 41–47.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993; 329: 673–682.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993; 329: 673–682.Crenshaw B.S., Granger C.B., Birnbaum Y., et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000; 101: 27–32.Crenshaw B.S., Granger C.B., Birnbaum Y., et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000; 101: 27–32.Arnaoutakis G.J., Zhao Y., George T.J., et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2012; 94: 436–444.Arnaoutakis G.J., Zhao Y., George T.J., et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2012; 94: 436–444.Tsai M.T., Wu H.Y., Chan S.H., et al. Extracorporeal membrane oxygenation as a bridge to definite surgery in recurrent postinfarction ventricular septal defect. ASAIO J 2012; 58: 88–89.Tsai M.T., Wu H.Y., Chan S.H., et al. Extracorporeal membrane oxygenation as a bridge to definite surgery in recurrent postinfarction ventricular septal defect. ASAIO J 2012; 58: 88–89.Rohn V., Spacek M., Belohlavek J., et al. Cardiogenic shock in patient with posterior postinfarction septal rupture-successful treatment with extracorporeal membrane oxygenation (ECMO) as a ventricular assist device. J Cardiovasc Surg. 2009; 24: 435–436.Rohn V., Spacek M., Belohlavek J., et al. Cardiogenic shock in patient with posterior postinfarction septal rupture-successful treatment with extracorporeal membrane oxygenation (ECMO) as a ventricular assist device. J Cardiovasc Surg. 2009; 24: 435–436.Gregoric I.D., Bieniarz M.C., Arora H., et al. Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J. 2008; 35: 46–49.Gregoric I.D., Bieniarz M.C., Arora H., et al. Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J. 2008; 35: 46–49.Assenza G.E., McElhinney D.B., Valente A.M., et al. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013; 6: 59–67.Assenza G.E., McElhinney D.B., Valente A.M., et al. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013; 6: 59–67.Thompson C.R., Buller C.E., Sleeper L.A., et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1104–1109.Thompson C.R., Buller C.E., Sleeper L.A., et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1104–1109.Schroeter T., Lehmann S., Misfeld M., et al. Clinical outcome after mitral valve surgery due to ischemic papillary muscle rupture. Ann Thorac Surg 2013; 95: 820–824.Schroeter T., Lehmann S., Misfeld M., et al. Clinical outcome after mitral valve surgery due to ischemic papillary muscle rupture. Ann Thorac Surg 2013; 95: 820–824.Russo A., Suri R.M., Grigioni F., et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation. 2008; 118: 1528–1534.Russo A., Suri R.M., Grigioni F., et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation. 2008; 118: 1528–1534.Goldstein J.A. Acute right ventricular infarction. Cardiol Clin 2012; 30: 219–232.Goldstein J.A. Acute right ventricular infarction. Cardiol Clin 2012; 30: 219–232.Marquez T.T., D’Cunha J., John R., et al. Mechanical support for acute right ventricular failure: evolving surgical paradigms. J Thorac Cardiovasc Surg. 2009; 137: e39–40.Marquez T.T., D’Cunha J., John R., et al. Mechanical support for acute right ventricular failure: evolving surgical paradigms. J Thorac Cardiovasc Surg. 2009; 137: e39–40.Kiernan M.S., Kri––shnamurthy B., Kapur N.K. Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction. J Invasive Cardiol. 2010; 22: E23–26.Kiernan M.S., Kri––shnamurthy B., Kapur N.K. Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction. J Invasive Cardiol. 2010; 22: E23–26.

The authors declare that there are no conflicts of interest present.